Connect with us

General Health

Teleradiology Market is Likely To Soar Around Worth Of US$3.63 Billion by 2023

Published

on

Press Release

The TMR report projects the global teleradiology market to register an impressive CAGR of 11.3% from 2015 to 2023. The market was valued US$1.35bn in 2014. By the end of 2023, the market will be worth US$3.63 bn, predicts the report.

Among various modalities, CT procedures account for a leading share in the market. This is expected to fuel demand in the teleradiology market due to its powerful imaging technology to observe complex bodily structures. Region wise, Asia Pacific is expected to contribute the largest share in the global teleradiology market in the coming years. This is attributed to a flourishing healthcare infrastructure and rapid technological advancements in healthcare sector in the region.

Rapid Advancements in Telecommunication Technologies Fuel Teleradiology Market

Teleradiology is a system of having medical images which are mostly interpreted by the radiologists from a distant location. Many non-invasive imaging modalities such as MRI, CT scan, ultrasound, X-rays help in proper disease treatment as well as diagnosis. However teleradiology helps in storing digital radiograph images through various software such as picture archiving and communication system (PACS) software. Rapid development of wireless technologies, rising demand for digital imaging in hospitals, and growing healthcare expenditure are major factors driving the global teleradiology market.

Furthermore, teleradiology is extensively used in mobile imaging companies, urgent care clinics, and hospitals. Rapid interpretation of images in emergency situations remotely, advancements in medical digital technology, and increasing demand for transmitting radiological images which are supported by telecommunication are also fueling the global teleradiology market. Apart from these, growing web technologies in healthcare sectors, increasing research and development activities in eHealth, and rising cases of long-term diseases are also boosting the global teleradiology market.

Request a Sample of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1132

Costly Teleradiology Infrastructures and Lack of Technicians Hinder Market Growth

Some of the challenges hindering the growth of the global teleradiology market are high cost of teleradiology infrastructure, absence of skilled professionals as well as less image data security, and lack of funds and internet connection in developing economies. Nonetheless, rising governments’ policies to set up teleradiology systems in several emerging economies is believed to help industry players overcome these challenges in the near future.

Transparency Market Research (TMR) notes that the global teleradiology market is categorized by the presence of several large and small players operating in it. Thus, the competitive landscape of the market has underwent successive fragmentation in the coming years. The rivalry between the potential players is likely to increase as they aim at exploring new revenue streams through collaborating with community hospitals.

Out of the various strategic alliances adopted by players in the global teleradiology market is to stay ahead of the competitors, bolstering product portfolio and expanding geographic reach for cementing their foothold in developing economies have paid off the most. The global teleradiology market is expected to grow steadily due to the existence of potentially large players who are capitalizing on their brand value for establishing their credibility in the market. Such leading vendors are also banking on their ability for innovative offerings to gain a competitive edge in the market. Some of the leading players in the global teleradiology are USA Radiology Management Solutions, vRad, and Radiology Reporting Online.

This post was originally published on Health News Office

Diseases & Disorders

CT Scanner Market SWOT Analysis & forecast by 2024

Published

on

CT Scanner Market
Press Release

The report includes the forecasts, analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry players. ICRWorld Market Research states that the world CT Scanner Market held an opportunity worth US$6031 Million in 2019. The market is expected to expand at 4.19% CAGR over the period between 2019 and 2024.

Request Sample PDF @ https://www.marketgrowthinsight.com/sample/39979

The latest market evaluation report on the CT Scanner Market explores how the CT Scanner market will continue to expand for the forecast period 2019 – 2024. The study further serves as a unique research for stakeholders, product owners, and field marketing executives looking for actionable data and unique resource on market size, share, and growth. The market intelligence report gives business evangelists an authority to review the major trends, opportunities, and challenges expected to shape the future of the industry during the estimated period.

CT Scanner Market Report Scope:
The CT Scanner Market answers all of your queries related to your needs and requirements. In addition, below are some of the questions the study answers,

  • A generalized idea of the market size for CT Scanner Market is established.
  • All the prominent players are recognized with a general portfolio and their share in the market are discussed.
  • The strategies employed by prominent players are unraveled.

Ask For Discount @ https://www.marketgrowthinsight.com/discount/39979 

Key Market Segments:

Global CT Scanner Market: Product Segment Analysis
Non-spiral scan CT
Single-slice spiral scan CT
Multi-slice spiral scan CT

Global CT Scanner Market: Application Segment Analysis
Head
Lungs
Pulmonary angiogram
Cardiac
Abdominal and pelvic
Extremities

The players mentioned in our report
GE Healthcare
Siemens
Toshiba
Shimadzu
Hitachi
Carestream Healthcare
NeuroLogica
Neusoft Medical
Shenzhen Anke High-tech
Philips
United-imaging

Our Media Distributor @  https://www.marketwatch.com/press-release/intraosseous-devices-market-2019-2030-analyzed-by-business-growth-application-and-future-prospects-2019-10-31

About us:
Market Growth Insight is a one stop solution for market research reports in various business categories. We are serving 100+ clients with 10000+ diverse industry reports and our reports are developed to simplify strategic decision making, on the basis of comprehensive and in-depth significant information, established through wide ranging analysis and latest industry trends.

We are striving to provide the best customer friendly services and appropriate business information to accomplish your ideas.

Contact Us:
tel: +13477675477 (US) , tel:+441314634161 (UK)
[email protected]
Website- https://www.marketgrowthinsight.com
Follow Us:- LinkedIn | Twitter | Google+ | Facebook
Content Source @ https://www.marketgrowthinsight.com/39979/ct-scanner-market

This post was originally published on Health News Office

Continue Reading

Diseases & Disorders

Migraine Drugs Market Upcoming Demand & Growth Analysis Up to 2025

Published

on

Migraine Drugs Market
Press Release

The global Migraine Drugs Market was valued at $1,713 million in 2017, and is expected to reach $2,190 million by 2025, growing at a CAGR of 3.1% from 2018 to 2025. Rise in awareness among patients for migraine treatment & prevention, rapid increase in female population, and surge in prevalence of migraine drive the growth of the global migraine drugs market. However, side effects associated with migraine drugs limit the market growth. On the contrary, growth opportunities in the developing nations and emerging new therapies for migraine treatment are expected to present opportunities for the market growth during the forecast period.

Request Sample Pages @ https://www.marketgrowthinsight.com/sample/38668

Research Methodology regarding Migraine Drugs Market
Research methodology regarding the Migraine Drugs Market borderlines on the specific procedures or techniques used to identify, select, process, and analyze information. A robust research methodology is carried out with an extreme systematic and a theoretical analysis to the said field of study. It encompasses concepts such as the required paradigm, theoretical models, quantitative and qualitative techniques. All possible parameters that may affect the markets covered in this research study are accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. To get a better hold on the market size of the current report, both, primary as well as secondary research methods are applied.

The report segments the migraine drugs market based on type, route of administration, distribution channel, and region. Based on type, the market is bifurcated into abortive medicine and preventive medicine. Depending on route of administration, it is fragmented into oral, injection, and others. By distribution channel, it is categorized into hospital-based Pharmacies, retail Pharmacies, and online Pharmacies. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Ask For Discount @ https://www.marketgrowthinsight.com/discount/38668

Key Market Segments

1.By Type
Abortive Medicine
Triptans (Serotonin Receptor Agonists)
Ergotamine Derivative
Other
Preventive Medicine
Anticonvulsant
Antidepressant
Beta Blocker
Others

2.By Route of Administration
Oral
Injection
Others

3.By Distribution Channel
Hospital-based Pharmacies
Retail Pharmacies
Online Pharmacies

4.The list of key players operating in this market includes:
Abbott Laboratories
Allergan Plc.
AstraZeneca
Eisai Co., Ltd.
Endo International Plc.
GlaxoSmithKline Plc.
Impax Laboratories
Johnson & Johnson
Merck & Co.
Pfizer Inc.

Conclusion for Migraine Drugs Market:
A Methodological and Detailed description for the Migraine Drugs market is presented above integrating various factors such as various companies’ strategies, prominent players, technological advancements, different production manufacturers and ongoing trends. The following report will serve as a valuable material for all the consumers befalling it.

Our Media Distributor @  https://www.marketwatch.com/press-release/intraosseous-devices-market-2019-2030-analyzed-by-business-growth-application-and-future-prospects-2019-10-31

About us:
Market Growth Insight is a one stop solution for market research reports in various business categories. We are serving 100+ clients with 10000+ diverse industry reports and our reports are developed to simplify strategic decision making, on the basis of comprehensive and in-depth significant information, established through wide ranging analysis and latest industry trends.

We are striving to provide the best customer friendly services and appropriate business information to accomplish your ideas.

Contact Us:
tel: +13477675477 (US) , tel:+441314634161 (UK)
[email protected]
Website- https://www.marketgrowthinsight.com
Follow Us:- LinkedIn | Twitter | Google+ | Facebook
Content Source @ https://www.marketgrowthinsight.com/38668/migraine-drugs-market

This post was originally published on Health News Office

Continue Reading

General Health

Thyroid Cancer Treatment Market: Manufacturer’s Revenue all Realized Positive Growth

Published

on

Press Release

AMA recently published a detailed study of over 180+ pages in its repository on ‘Thyroid Cancer Treatment’ market  covering interesting aspects of market with supporting development scenario till 2025. The study provides market size break-up by revenue and volume* for  emerging countries and important business segments along with commentary on trending factors, growth drivers. Profiled players in study from the coverage used under bottom-up approach are Baxter International Inc. (United States),Mylan Pharmaceuticals Inc. (United States),Alara  Pharmaceuticals Corp. (United States),Bristol Myers Co. (United States),Abbott Laboratories (United States)


Next step one should take to boost sales? Track latest strategic steps and current scenario analysis of the market @ https://www.advancemarketanalytics.com/sample-report/57101-global-thyroid-cancer-treatment-market

According to the American Cancer Society (ACS), Thyroid cancer accounted for approximately 47,230 in women and 15,220 in men in the United States in the year 2015. Increase in geriatric population and rising prevalence of hyperthyroidism and hypothyroidism patients are driving the Global Thyroid Cancer treatment market.  Thyroid cancer is also known as papillary carcinoma is cancer that develops from the tissues of the thyroid gland. The type of cancer in which cells grows abnormally and have the potential to spread to other parts of the body. Symptoms can include swelling or a lump in the neck.  Follicular cancer, medullary cancer, and Anaplastic cancer are different types of thyroid cancers. The treatments which is available for thyroid cancer are the surgical removal of the thyroid gland, radioactive ablation, and thyroid stimulating hormone (TSH) suppression therapy. In the initial stage or metastasis, stage chemotherapy has also been opted for the treatment.

Market Segmentation
by  Type (Surgery, Iodine Therapy, External Radiotherapy, Thyroxin Treatment, Chemotherapy, Drugs), Application (Hospitals, Oncology centers, Hospital Pharmacies, Retail Pharmacies), End user (Hospital Associated Labs, Independent Diagnostic Labs, Diagnostic Imaging Centers, Cancer Research Institutes, Others)

Make an enquiry before buying this Report @ https://www.advancemarketanalytics.com/enquiry-before-buy/57101-global-thyroid-cancer-treatment-market

What’s Trending in Market:
The high development figure for the thyroid growth therapeutics market is credited to a strong pipeline.

Growth Drivers:

Increasing prevalence and incidence of thyroid cancer

Increasing risk factors and high environmental exposure of thyroid cancer patients

Government support and reimbursement policies for thyroid cancer treatment market.

Restraints:

Exposure to radiation or patient undergoing radiation therapy may hamper the market.

View Detailed Table of Content @ https://www.advancemarketanalytics.com/reports/57101-global-thyroid-cancer-treatment-market

Country level Break-up includes:
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Netherlands, Switzerland, Nordic, Others)
Asia-Pacific (Japan, China, Australia, India, Taiwan, South Korea, Middle East & Africa, Others)

* Customized Section/Chapter wise Reports or Regional or Country wise Chapters are also available.

 

On Special Request we do offer a dedicated and focus report on regional or by country level scope.

Get full copy of China Thyroid Cancer Treatment Market Study @ ——— USD 2000

And, Asia-Pacific Thyroid Cancer Treatment Market Study @ ——— USD 2500

Extracts from TOC

 

1 Study Coverage

Industry Definition

…..

2 Executive Summary

Global Thyroid Cancer Treatment Market Size (2014-2025) by Revenue, Production*, Growth rate

Analysis of Competitive Landscape – Insights on Market Development Scenario

3 Market Size by Manufacturers [Market Share, Global Rank etc]

4 Global Thyroid Cancer Treatment Production, Consumption by Regions (2014-2025)

5 Market Size by Type

Global Thyroid Cancer Treatment Revenue by Type

Global Thyroid Cancer Treatment Volume by Type

Global Thyroid Cancer Treatment Price by Type

6 Market Size by Application (2014-2025)

Global Thyroid Cancer Treatment Breakdown Data by Revenue, Volume

7 Manufacturers Profiles

8 Value Chain and Sales Channels Analysis

Buy this report @ https://www.advancemarketanalytics.com/buy-now?format=1&report=57101

Contact Us:
CRAIG FRANCIS (PR & Marketing Manager)
[email protected]

Ph: +1 (206) 317 1218

 

This post was originally published on Health News Office

Continue Reading

Trending